2015 American Transplant Congress Archives - Page 118 of 170

Early Allograft Dysfunction Causes Inferior Patient and Allograft Survival in Liver Transplantation; an Experience of 1952 Consecutive Liver Transplants

D. Lee, K. Croome, J. Burns, D. Perry, J. Nguyen, H. Crespo, C. Taner.
Early Antibody Mediated Rejection in HLA Antibody Incompatible Kidney Transplantation – A Treatable Condition Without Heavy Induction Immunosuppression

S. Daga,^1,2 N. Krishnan,¹ D. Lowe,³ F. Lam,¹ C. Imray,^1,2 H. Kashi,¹ L. Tan,¹ D. Briggs,³ R. Higgins.^1,2
Early Clinical Indicators of Long Term Survival and Allograft Loss Following De Novo DSA. A 15-Year Longitudinal Study

M. Everly,¹ L. Rebellato,² K. Briley,² A. Maldonado,³ P. Bolin,² C. Haisch,² W. Kendrick,⁴ S. Kendrick,⁴ C. Morgan,² R. Harland,² P. Terasaki.¹
Early Conversion to Everolimus in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

J. de Fijter, H. Holdaas, A. Speziale, G. Junge, Z. Wang, J. Cruzado, M. van der Giet.
Early Detection of HCC Mutations in Indeterminate Lesions Using Liquid Biopsies

Y. Lin,¹ K. Cavaness,² Z. Zhang,¹ S. Lin,³ K. Korenblat,¹ G. Klintmalm,² W. Chapman.¹
Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
Early Hospital Readmission and Distance from Transplant Center

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
Early Hospital Readmissions After Kidney Transplantation

M. Lubetzky, M. Ajaimy, L. Kamal, G. DeBoccardo, E. Akalin, L. Kayler.
Early Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Has No Negative Impact on Patients outcome'

B. Lowry,¹ W. El Moghazy,^1,2 G. Meeberg,¹ N. Kneteman.¹
Early Relapse of Atypical HUS Following ABO Incompatible Living Related Paediatric Renal Re-Transplant Successfully Treated With Eculizumab

J. Stojanovic,¹ A. Adamusiak,² N. Sebire,³ S. Marks,¹ N. Mamode.²
Early Steroid Withdrawal and Calcineurin Inhibitor Minimization Protocols for Maintenance Immunosuppression: A Single Center 10-Year Experience

R. Lopez-Soler,¹ L. Park,³ J. Martinolich,² D. Conti.¹
Early Steroid Withdrawal and Infection Risk in Kidney Transplant Recipients

S. Bae, L. Kucirka, C. Durand, B. Orandi, R. Avery, D. Segev.
Early Use of Anti-Lymphocyte Antibody in Kidney Transplant Recipients With Delayed Graft Function Can Produce Desirable Post-Transplant Results

J. Lee, J. Lee, D. Joo, K. Huh, S. Kim, Y. Kim, M. Kim.
Early Vs. Late Acute Antibody Mediated Rejection Among Renal Transplant Recipients in Terms of Its Response to Rituximab Therapy-Single Center Expereince

N. Nampoory, T. Alotaibi, O. Gheith, M. Halim, T. Mahmoud, P. Nair, M. Abdulmoneim, S. Alwaheb, R. Hasan.
Early Weight Gain After Transplantation Can Cause Adverse Effect On Transplant Kidney Function

S. Choi, I.-K. Kim, S. Son, M. Ju.
ECDI Fixed Donor Splenocytes Combined With α-1 Antitrypsin Induce Immune Tolerance in Mice Cardiac Transplantation Model

G. Chen,¹ X. Lai,¹ J. Qiu,¹ L. Qiu,² X. Mai,² L. Chen.¹
Economic Analysis of Kidney Transplant Tolerance: The Holy Grail Is Less Costly

N. Elias, S. Shao, T. Gift, B. Patel, A. Cosimi, T. Kawai.
Eculizumab as a Rescue Therapy for Rhinovirus-Induced Antibody Mediated Rejection After Incompatible Kidney Transplantation

E. Tantisattamo, A. Shetty, B. Ho, L. Gallon, J. Friedewald.
Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

D. Glotz,¹ G. Russ,² L. Rostaing,³ C. Legendre,⁴ S. Chadban,⁵ J. Grinyo,⁶ N. Mamode,⁷ E. Cozzi,¹¹ Y. Lebranchu,⁸ S. Sandrini,⁹ L. Couzi,¹² W. Marks.¹⁰
Eculizumab in the Treatment of Early Severe Acute Antibody Mediated Rejection Following HLA-Compatible Kidney Transplantation-Case Series

M. Singh,¹ N. Macias,² V. Tatapudi,¹ B. Lee.¹
Educating Hispanic ESRD Patients About Living Donation: Impact of a Brief Intervention

E. Alvaro, J. Siegel, J. Poulsen, E. O'Brien.
Educating the Less Prepared: Transplant Knowledge and Decision-Making Differences by Race at Onset of Evaluation

A. Waterman,¹ J. Peipert,¹ S. Brann,² C. Kynard-Amerson,¹ M. Robbins,³ A. Paiva,³ A. Gaber.²
Education and Employment After Renal Transplantation in Young Adults: An International Study

J. Gralla,¹ P. Murray,² A. Wiseman,¹ P. Harden.³
Effect of 2007 CMS Conditions of Participation on High Risk Renal Transplantation: A Study of the United States Renal Data System

D. John, A. Brar, F. Tedla, N. Sumrani, E. Timpo, M. Salifu.
Effect of Antibody Mediated Rejection on Long-Term Renal Allograft Function

M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.
Effect of Center Volume On Kidney Transplant Outcomes- Mate Kidney Analysis

T. Klair,¹ P. Friedmann,² L. Kayler.²
Effect of Distinct Immunosuppressive Protocols On the Profile of Cytokines Expression in Renal Transplant Recipients of Extended Criteria Donor Kidneys

C. Montoro Mazeti,¹ C. Zangrossi Dezotti,¹ I. Fernandes-Charpiot,^1,2 H. Caldas,¹ M. Baptista,^1,2 M. Abbud Filho.^1,2,3
Effect of Donor Age On Pancreas Transplantation Outcome

A. Rathnasamy Muthusamy,¹ G. Vrakas,¹ S. Mittal,¹ S. Reddy,¹ I. Quiroga,¹ J. Gilbert,¹ R. Ploeg,² E. Sharples,¹ S. Sinha,¹ A. Vaidya,¹ P. Friend.²
Effect of Everolimus on Cardiovascular Parameters in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

H. Holdaas,¹ M. van der Giet,¹ J. de Fijter,¹ A. Speziale,² C. Escrig,² G. Junge,² Z. Wang,³ J. Cruzado.¹
Effect of Everolimus on Left Ventricular Hypertrophy in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

M. van der Giet,¹ H. Holdaas,¹ J. de Fijter,¹ A. Speziale,² C. Escrig,² G. Junge,² Z. Wang,³ J. Cruzado.¹
Effect of Everolimus Versus Tacrolimus On Left Ventricular Hypertrophy in Renal Transplant Patients On Maintenance

J. Morales,¹ J. Pascual,² A. Sánchez-Fructuoso,³ D. Serón,⁴ J. Díaz,⁵ F. Oppenheimer,⁶ M. Rengel,⁷ D. Hernández,⁸ J. Cruzado,⁹ On Behalf of Evita Study Group.
Effect of Extension in Submucosal Ureteral Tunnel to Prevent Vesicoureteral Reflux and Its Impact on the Graft Survival in Kidney Transplantation

T. Inoue,¹ S. Satoh,² M. Saito,¹ K. Numakura,¹ H. Tsuruta,¹ S. Akihama,¹ S. Narita,¹ N. Tsuchiya,¹ T. Habuchi.¹
Effect of Fully Laparoscopic Left Hepatectomy on Donor Interest in Living Donor Liver Transplantation (LDLT)

A. Yegiants, D. Santamour, T. Mansour, J. Pisa, J. Emond, B. Samstein.
Effect of Induction in Renal Transplant Recipients Aged 70 and Over

M. Lubetzky, M. Ajaimy, L. Kamal, G. DeBoccardo, E. Akalin.
Effect of Intrapatient Variability and Mean Tacrolimus Levels in Renal Transplant Patients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Effect of Living Kidney Donation on Glucose Metabolism and Insulin Resistance

B. Tanriover,¹ P. Mohan,² S. Cremers,³ I. Lingvay.⁴
Effect of Patient Functional Status on the Associations Between Kidney Transplant Waitlisting, Race, and U.S. Region

L. Plantinga, R. Patzer, S. Pastan, C. Bowling.
Effective Control of Anti-Xenogeneic IL-17 Response for Tolerance Induction in Xenogeneic Islet Cell Transplantation

H. Kang,¹ S. Wang,^1,2 X. Zhang,³ L. Zhang,¹ S. Miller,⁴ B. Hering,⁵ X. Luo.^1,3,4
Effective Long-Term Prophylaxis against De Novo Hepatitis B With Hepatitis B Vaccination in Pediatric Recipients of HbcAb-Positive Liver Grafts

S. Lee, J.-M. Kim, G.-S. Choi, C.-H. Kwon, J.-W. Joh, S.-K. Lee.
Effectiveness of Neovascularization Surrounding Engrafted Islets by Matrigel With Additional Growth Factors in Intramuscular Islet Transplantation

G. Yoshimatsu,^1,2 N. Sakata,² H. Tsuchiya,² M. Takita,³ M. Levy,³ B. Naziruddin,³ M. Unno.²
Effectiveness of Protocol-Driven Induction Therapy in Adult Kidney Transplant Recipients

J. Casale, J. Fleming, D. Taber, C. Staino, K. Boyle, K. Covert, N. Pilch, H. Meadows, C. Mardis, K. Chavin, C. Bratton, J. McGillicuddy, T. Srinivas, P. Baliga.
Effector T Cell Migration to Pancreatic Islet Allografts Is Dependent On Donor Antigen Recognition and Not Gαi Chemokine Signaling

Q. Zhang, H. Dai, Q. Zeng, A. Williams, M. Oberbarnscheidt, F. Lakkis.
Effects of Anti-Human Leukocyte Antigen Antibody After Heart Transplantation

F. Liou, M. Kittleson, J. Patel, S. Siddiqui, M. Luu, B. Kearney, D. Ramzy, D. Chang, L. Czer, N. Reinsmoen, J. Kobashigawa.
Effects of Early Everolimus Use for Immunosuppression in Living Donor Liver Transplant Recipients- An Analysis of 215 Sequential Patients

A. Thorat, Y.-W. Hsieh, H.-R. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu, L.-B. Jeng.
Effects of Heart and Lung Co-Transplantation Across a Full MHC Barrier in Miniature Swine

M. Madariaga, P. Spencer, S. Michel, G. La Muraglia II, M. O'Neil, E. Mannon, C. Leblang, I. Rosales, R. Colvin, D. Sachs, J. Allan, J. Madsen.
Effects of Immunosuppressives On Porcine Renal Microvascular Endothelial Cell–Activated Human T Cell Proliferation: A Cellular Model of Kidney Xenotransplantation In Vitro

Z.-Y. Wang, M. Tector, S. Nagai, J. Butler, R. Blankenship, S. Downey, J. Estrada, P. Li, A. Tector.
Effects of Late Kidney Graftectomy in Nonhuman Primates (NHPs) Tolerant of Co-Transplanted Heart and Kidney Allografts

M. Tonsho,¹ G. Benichou,¹ R. Smith,² R. Colvin,² J. Madsen.^1,3
Effects of Mast Cell Stabilization on the Development of Aspiration-Induced Fibrosis in a Rat Model

E. Sapmaz, Z. Sun, J.-C. Chang, N. Sanders, S. Bell, M. Everett, Z. Holzknecht, W. Parker, R. Davis, S. Lin.
Effects of the Allo-Immune Response On Nerve Regeneration in Vascularized Composite Allotranplantation

S. Tuffaha,¹ J. Budihardjo,¹ P. Afrooz,² K. Sarhane,¹ R. Jindal,² D. Cooney,¹ G. Brandacher,¹ W. Lee.¹
Effects of Toll Like Receptor (TLR) Signaling on Murine Alloimmunity Are Modulated by Immune Cell Derived Complement

J. Sheen, P. Heeger.
Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy

K. Takahashi,¹ K. Saito,² S. Takahara,³ S. Fuchinoue,⁴ T. Yagisawa,⁵ A. Aikawa,⁶ Y. Watarai,⁷ N. Yoshimura,⁸ K. Tanabe,⁴ K. Morozumi,⁹ M. Shimazu.¹⁰
Efficacy and Safety of Induction Therapy With Monoclonal Versus Polyclonal Antibodies in Kidney Transplant Recipients in the Last Five Years (2008-2013) in Our Institution

M. Fernández, M. López, M. Ferreira, A. Aguilar, C. Jiménez, R. Selgas.
Efficacy and Safety of Once-Daily Everolimus With Minimized Once-Daily Tacrolimus After Liver Transplantation

P. De Simone,¹ P. Carrai,¹ L. Coletti,¹ A. Precisi,² D. Campani,³ F. Filipponi.¹
Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

C. Sommerer,¹ K. Budde,¹ V. Kliem,¹ O. Witzke,¹ M. Guba,¹ J. Jacobi,¹ B. Vogt,³ I. Hauser,¹ P. Reinke,¹ R. Stahl,¹ T. Rath,¹ M. Porstner,² D. Baeumer,² M. Zeier,¹ W. Arns,¹ F. Lehner.¹
Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients

R. El Ramahi,² S. Habib,¹ S. Rosen,³ S. Farran,³ C. Walker,³ J. Shubeilat,⁴ S. Yost,⁵ O. McCotter,⁶ M. Cassal,⁶ A. Rana,⁷ T. Boyer,¹ T. Zangeneh.²
Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

S. Narumi,¹ Y. Watarai,¹ N. Goto,¹ T. Hiramitsu,¹ T. Yamamoto,¹ M. Tsujita,¹ M. Okada,¹ K. Futamura,¹ A. Takeda,² T. Kobayashi.³
Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

A. Weick,¹ K. George,¹ S.-M. Jafri,² D. Moonka.²
Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial

S. Bunnapradist,¹ J. Denny,² M. Waybill,³ P. West-Thielke,⁴ S. Steinberg.⁵
Efforts to Improve Living Kidney Donor Follow-Up Reporting Have Been Successful

J. Wainright,¹ M. Dew,² C. Lougee,¹ S. Taranto,¹ L. Bolton,¹ C. Thomas.³
Elderly ESRD Patients Have a Significantly Narrowed T-Cell Receptor Repertoire Diversity

L. Huang,¹ A. Langerak,² I. Wolvers - Tettero,² R. Meijers,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹
Elderly Transplant Recipients Have Improved Graft Survival

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
Elective Allograft Nephrectomy After Transplant Failure

J. Augustine, K. Woodside, K. Noon, D. Hricik, E. Sanchez, J. Schulak.
Electronic Health Service to Improve Therapeutic Drug Monitoring of Immunosuppressants

M. Barten,¹ J. Garbade,² I. Hausladen,² F. Mohr.²
Elevated Cancer Risk Among US Pediatric Solid Organ Transplant Recipients

E. Yanik,¹ J. Smith,² M. Shiels,¹ C. Clarke,³ C. Lynch,⁴ A. Kahn,⁵ L. Koch,⁶ K. Pawlish,⁷ E. Engels.¹
Elevated Pre-Transplant Serum Troponin Is Associated With an Increased Risk of Mortality in Elderly Kidney Transplant Recipients

G. Desbuissons,¹ J. Golmard,² H. Lazareth, M. Timsit,³ H. Kreis, D. Anglicheau, C. Legendre,¹ R. Snanoudj,¹ F. Martinez.¹
Elevated ST2 Levels Are Associated With Increased Risk of Antibody Mediated Rejection in Heart Transplant Recipients

A. Grupper,¹ S. Kushwaha,¹ O. Abou Ezzeddine,¹ J. Geske,² W. Kremers,² B. Edwards,¹ N. Pereira.¹
Emerging Application of Active Immune Targeted Delivery in Transplantation

M. Uehara,¹ A. Jamil,¹ M. McGrath,¹ Z. Solhjou,¹ N. Banouni,¹ S. Tullius,² C. Jianjun,³ R. Abdi.¹
Emerging Strategies to Screen Kidney Offers Based on the Kidney Donor Profile Index (KDPI)

D. Stewart,¹ A. Kucheryavaya,¹ G. Boyle,¹ R. Metzger,^2,3 M. Aeder,⁴ R. Formica.⁵
Emotional Bonding in Recipients of Deceased Donor Kidney Transplants (DDRT): Associated Factors and Effect on Medication Adherence

A. Cerrato, M. Salifu, M. Markell.
End of Treatment Liver Biopsy With Sofosbuvir: Histologic Changes Suggestive of Hepatitis C Activity in Liver Transplant Recipients With Achieved SVR

B. Ismail,¹ X. Zervos,¹ P. Bejarano,² M. Waton,¹ D. Beltran,³ D. Sears,¹ A. Tzakis.¹
End-To-End Ureteropyelostomy With Ligation of the Native Ureter in Kidney Transplantation: Is It a Safe Procedure?

H. Marinho Neto,¹ B. Leslie,¹ J. Neves Neto,¹ M. Almeida,¹ S. Ximenes,¹ W. Aguiar,¹ H. Tedesco,² J. Medina Pestana,² R. Soler.¹
Endosome-Based Activation of Non-Canonical NF-kB Signaling By Membrane Attack Complexes

D. Jane-wit,¹ Y. Surovtseva,² L. Qin,³ P. Clark,⁴ T. Manes,⁴ M. Kashgarian,⁵ N. Kirkiles-Smith,⁴ R. Liu,⁴ C. Wang,⁴ G. Tellides,³ J. Pober.⁴
Endovascular Salvage of a Pancreas Allograft Having Developed a Large AV Fistula and Aneurysm

N. Katariya,¹ R. Batra,¹ A. Moss,¹ K. Reddy,¹ A. Mathur,¹ E. Huettl,² S. Naidu,² A. Singer.¹
Engagement of the Vasopressin Receptor On Hepatocytes Protects Liver from Ischemia-Reperfusion Injury Via the WNT-β-Catenin-SGK1-FOXO Pathway

X. Liu,¹ T. Billiar,² R. Tao.¹
Enhanced Production of Macrophage Chemoattractant Protein-1 (MCP-1) Within the Kidney in Brain Death Donors Predicts Recipient Allograft Function

J. Chen, S. Antipenko, A. Zmijewska, R. Reed, J. Locke, R. Mannon.
Enhanced Requirement for TNF Signaling on Low Affinity Memory CD8+ T Cells During Heterologous Immunity

S. Krummey,¹ C.-W. Chen,¹ D. Liu,¹ M. Wagener,¹ B. Evavold,² C. Larsen,¹ M. Ford.¹
Enhancing Kidney Function Following DCD Donation With Thrombolytic Therapy: A Preliminary Report of a Multicenter Prospective Quasi-Blinded Randomized Trial

K. Woodside,¹ D. Goldfarb,² J. Rabets,² E. Sanchez,¹ D. Lebovitz,³ J. Schulak,¹ J. Fung,² B. Eghtesad.²
Eomes-Expressing CD8+ T Cells and Th17 Cells Mediate Costimulatory Blockade-Resistant Allograft Rejection in Mice

M. Sabet-Baktach,¹ E. Eggenhofer,¹ P. Renner,¹ M. Lantow,¹ H. Schlitt,¹ E. Geissler,¹ A. Kroemer.^1,2
Eomesodermin Expression By Alloreactive Non-Human Primate CD8+ Memory T Cells: Influence of CTLA4Ig and Regulatory DC Infusion in Renal Allograft Recipients

M. Ezzelarab,¹ L. Lu,¹ H. Guo,¹ A. Zahorchak,¹ W. Shufesky,¹ D. Cooper,¹ A. Morelli,^1,2 A. Thomson.^1,2
Eosinophilic Gastrointestinal Disease in Pediatric Liver and Kidney Transplant Recipients

S. Mohammad,¹ J. Bush,² K. Amsden,¹ A. Kagalwalla,¹ H. Melin-Aldana,² N. Arva.²
Epidemiologic Change in Pulmonary Hypertension Patients Referred for Lung Transplantation Post Lung Allocation Score Implementation

R. Loyaga-Rendon,¹ B. Shelton,¹ R. Reed,¹ J. Tallaj,¹ E. Diaz-Guzman,¹ G. Heresi,² J. Locke.¹
Epidemiology and Outcomes of Non Tuberculous Mycobacterial (NTM) Infections in Solid Organ Transplant (SOT) Recipients

I. George, C. Santos, M. Olsen, T. Bailey.
Epidemiology and Outcomes of Pre-Transplant Methicillin Resistant Staphylococcus Aureus Screening in Pediatric Solid Organ Transplant Candidates

G. Paulsen, S. Blum, L. Danziger-Isakov.
Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?

K. Doucette, M. Charles, M. Al Dabbagh, J. Preiksaitis.
Epidemiology of Pneumonia in a Cohort of 5,000+ Abdominal Solid Organ Transplant Recipients

A. Masica, S. Delcroix-Lopes, M. Kouznetsova, C. Spak.
Epigenetic Reprogramming of Murine Cytomegalovirus Immediate Early Genes Induced By Renal Transplantation

M. Hummel,¹ X.-F. Liu,¹ C. Jie,¹ Z. Zhang,¹ S. Yan,¹ J.-J. Wang,¹ S. Kurian,² D. Salomon,² M. Abecassis.¹
Epstein Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production in B Cell Lymphomas

A. Harris-Arnold, S. Schaffert, O. Hatton, C. Esquivel, S. Krams, O. Martinez.
Erythropoietin (EPO) Has Treg Sparing Immunosuppressive Effects On Human Alloreactive T Cells

C. Purroy, P. Heeger, P. Cravedi.
Establishment of a Novel Model for Hypothermic Machine Perfusion In Vivo in Rabbits

Z. Zhong,¹ Z. Liu,¹ R. Wang,¹ Z. Fu,² Y. Zhang,² Q. Hu,¹ K. Jin,¹ D. Ko,³ Y. Wang,¹ Q. Ye.^1,2
Establishment of Diabetes Modeling in Common Marmoset

W. Yuan,¹ S. Fukuda,¹ T. Inoue,² D. Chujo,¹ H. Okochi,¹ E. Sasaki,² M. Shimoda.¹
Estimated Prevalence of HIV in Kidney Transplant Candidates

A. Shaffer, X. Luo, L. Kucirka, A. Cash, A. Massie, C. Durand, D. Segev.
Estimation of Glomerular Filtration Rate With Serum Cystatin C Accurately Discriminates Renal Dysfunction in Liver Transplant Candidates With End-Stage Liver Disease

S. Gonzalez,¹ J. Trotter,¹ H. Szerlip,² M. Levy,³ A. Chandrakantan,⁴ A. Yango,⁴ A. Rajagopal,⁴ Y. Barri,⁴ K. Rice,⁴ M. Saim,² L. Melton,⁴ M. Emmett,² G. Klintmalm,³ B. Fischbach.⁴
Etanercept for Graft Versus Host Disease Following Liver Transplantation

E. Ticehurst,¹ E. Blumberg,¹ F. Vyas,¹ K. Olthoff,¹ A. Shaked,¹ S. Bruno,¹ K. Butcavage,¹ E. Knight,¹ G. Smith,¹ S. Gill.²
Ethnic Barriers in Pediatric Liver Transplant Recipients. A Retrospective Study

M. Asolati,¹ T. Pillen,¹ R. Romero,² T. Heffron.¹
Etiology, Incidence and Outcomes of the Highly Sensitized Kidney Transplant Patient

R. Redfield, T. Zens, J. Scalea, M. Rizzari, D. Mandelbrot, D. Kaufman, A. Djamali.
European ELITA ELTR Multicenter Survey On the Management of Bile Duct During Liver Procurement, Preservation and Transplantation

N. Meurisse,¹ D. Monbaliu,¹ P. Muiesan,² A. Pascher,³ M. Oliverius,⁴ G. Berlakovich,⁵ R. Adam,⁶ I. Senesael,¹ J. Pirenne.¹
Evaluating Outcomes in Multi-Organ Liver Transplant Recipients

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ B. Thompson,¹ J. Zeglin,¹ D. Schladt,¹ J. Lake,² W. Kim,³ A. Israni,¹ B. Kasiske.¹
Evaluating the Benefits of Everolimus on Cardiac Allograft Vasculopathy: Further Evidence from Results of Imputations for Missing IVUS Data from A2310 Study

P. Lopez,¹ G. Dong,² Z. Wang.²
Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients

L. Donohue, W. Ally, S. Dunn, J. Kennedy, J. Bergin.
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT

R. Bray,¹ H. Gebel,¹ R. Townsend,² U. Meier-Kriesche,² C. Larsen.¹
Evaluation of Geographically Distant Living Kidney Donors: A Barrier to Living Donation?

F. Weng, N. Dhillon, L. Davis, R. Goldberg, A. Patel, K. Tibaldi, M. Morgievich, S. Mulgaonkar.
Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy: A Single Center Experience

N. Nesselhauf,¹ J. Strutt,² B. Bastani.¹
Evaluation of Medication Regimen Complexity Over Time Following Heart Re-Transplantation

B. Bryant,¹ A. Libby,¹ R. Page,¹ J. Lindenfeld,² C. Aquilante.¹
Evaluation of Natural Killer Cell Activation by NK Cell-Specific Interferon-Gamma-Releasing Assay

J. Ryu,¹ K. Park,¹ Y. Kim,² E.-J. Oh.²
Evaluation of Preformed Anti-HLA Antibody of "Unknown Origin" after Kidney Transplant in a Brazilian Center

D. Glasberg,¹ D. Monteiro de Carvalho,² T. Matuck,² G. Fabricio-Silva,³ M. Barbosa,¹ A. Borela,¹ L. Christiani,¹ R. Malta,¹ L. Porto.³
Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients

X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.
Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients

E. Aldag, S. Farrell, R. Pedersen, A. Sahajpal, J. Clendenon, V. Gunabushanam, D. Kramer.
Evaluation of the Gastrointestinal Tract as a Potential Route of Primary Polyomavirus Infection

G. Huang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.
Everolimus and Early Calcineurin Inhibitor Withdrawal Is Associated With Superior Renal Function: 5-Year Follow-Up of the Randomized PROTECT Liver Transplantation Study

M. Sterneck, G. Kaiser, N. Heyne, N. Richter, F. Rauchfuss, A. Pascher, P. Schemmer, L. Fischer, C. Klein, S. Nadalin, F. Lehner, U. Settmacher, D. Gotthardt, M. Loss, S. Ladenburger, P. Wimmer, M. Dworak, H. Schlitt.
Everolimus Conversion to Treat BK Virus Infection in Kidney Transplant Recipients

D. Wojciechowski, A. Webber, S. Chandran, F. Vincenti.
Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.
Everolimus Plus Reduced-Exposure Calcineurin Inhibitor Versus Mycophenolate Mofetil Plus Standard-Exposure Calcineurin Inhibitor: 2-Year Results in Living Donor Kidney Transplant Recipients

Y. Watarai,¹ N. Akutsu,² K. Saito,³ Y. Nakagawa,³ O. Kamisawa,⁴ T. Kenmochi.⁵
Everolimus Versus Mycophenolate for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin and Tacrolimus

H. Tedesco-Silva,¹ C. Felipe,¹ A. Ferreira,¹ M. Cristelli,¹ A. Bessa,¹ P. Ueno,¹ T. Sandes- Freitas,¹ G. Bassos,¹ W. Aguiar,² H. Proença,³ J. Medina-Pestana.¹
Everolimus With Low Dose Tacrolimus in Intestinal Transplantation

T. Beduschi, J. Garcia, J. Lugo-Baruqui, J. Fan, S. Nishida, J. Jebrock, A. Tekin, G. Selvaggi, P. Ruiz, R. Vianna.
Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation

P. De Simone,¹ P. Carrai,¹ L. Coletti,¹ D. Ghinolfi,¹ D. Campani,² F. Filipponi.¹
Evolution of GFR Outcomes During the First Year of Transplant According to the Kidney Donor Risk Index Transplantation in México. The Experience of a Single Center

J. Aguilar-Frasco, J. Arreola-Guerra, L. Paláu, V. Visag, M. Vilatobá, A. Contreras, A. Sanchez, J. Alberu.
Evolution of Urinary Albumin Excretion in a Large Cohort of Kidney Donors: No Evidence of Progression

H. Ibrahim, D. Berglund, A. Matas.
Ex Vivo Expansion With Rapamycin Enhances the Suppressive Function of Regulatory T Cells (Tregs) Isolated from Pediatric Thymus

E. Dijke,^1,2,3 R. Hoeppli,^3,4 T. Ellis,^1,2 J. Pearcey,^1,2 I. Larsen,^1,2 I. Rebeyka,^1,2 D. Ross,^1,2 M. Levings,^3,4 L. West.^1,2,3
Ex Vivo Lung Perfusion: Revisit to the Optimal Oxygenation Circulating Lungs for Graft Preservation

K. Noda, S. Haam, J. D'Cunha, J. Luketich, C. Bermudez, N. Shigemura.
Ex Vivo Stem Cell-Mediated Regeneration of Ischemically Damaged Renal Allografts

L. Brasile, N. Henry, A. Meyer, B. Stubenitsky.
Examining Long-Term Survivors in Combined Heart-Lung Transplantation

S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
Excellent Outcomes of Prophylactic Rituximab Administration With Plasmapheresis in Kidney Transplant Recipients With Focal Segmental Glomerulosclerosis

M. Okumi,¹ Y. Miyauchi,² T. Yagisawa,¹ K. Unagami,¹ D. Toki,¹ K. Omoto,¹ H. Ishida,¹ K. Tanabe.¹
Excellent Outcomes With Deceased Donor Kidney Transplants With a Terminal Creatinine >= 3

L. Matsuoka,¹ E. Alicuben,¹ K. Woo,¹ H. Shidban,¹ Y. Qazi,² M. Smogorzewski,² S. Alexopoulos.¹
Excellent Outcomes With Kidney Transplantation for Patients ≥70 Years of Age

D. Haakinson,¹ K. Reddy,¹ A. Moss,¹ N. Katariya,¹ A. Singer,¹ A. Mathur,¹ J. Huskey,² H. Khamash,² R. Heilman.²
Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?

A. Islam,¹ A. Lawless,¹ L. Teeter,³ E. Graviss,³ D. Victor,⁴ A. Sadhu,⁴ S. Patel,⁶ A. Gaber,¹ R. Knight.¹
Exercise Therapy Improves Body Composition Change After Kidney Transplantation

M. Miura, H. Higashiyama.
Expanding the Donor Pool: Comparison of Outcomes in DCD Vs Living Donor Liver Transplantation

G. Sapisochin,¹ J. Seal,² N. Goldaracena,¹ T. Reichman,² J. Laurence,¹ H. Bohorquez,² I. McGilvray,¹ D. Bruce,² P. Greig,¹ I. Carmody,² M. Cattral,¹ A. Ghanekar,¹ D. Grant,¹ G. Loss,² M. Selzner.¹
Expanding the Living Donor Pool: Results of ABO Incompatible Living Related Kidney Transplantation

T. Vowinkel,¹ S. Reuter,² C. Anthoni,¹ N. Senninger,¹ B. Suwelack,² H. Wolters.¹
Expedited Placement of Donor Hearts Increases Morbidity and Mortality Among Bypassed Potential Recipients – A Single Center Experience

M. Peltz,¹ M. Drazner,² M. Jessen.¹
Experimental Study Using Contrast-Enhanced Ultrasonography to Evaluate Rat Chronic Allograft Nephropathy Model and the Relationship Between Hemodynamic Parameters and Renal Allograft Fibrosis

Q. Zhang,¹ Z. Yu,² Y. Xu,¹ S. Zeng,¹ W. Xue,¹ X. Hu.¹
Explorative Analysis of ZEUS After 5 Years: Histological Assessment from Biopsy Analyses

U. Eisenberger,¹ K. Budde,¹ O. Witzke,¹ F. Lehner,¹ C. Sommerer,¹ R. Wuethrich,³ P. Reinke,¹ A. Muehlfeld,¹ K. Heller,¹ R. Stahl,¹ H. Wolters,¹ I. Hauser,¹ M. Porstner,² W. Arns.¹
Expression Patterns of Neuropilin-1 On T Cells and a Potential Role in Transplantation

E. Lee, H. Kim, G. Demirci.
Extended Analysis of Tocilizumab (anti-IL-6R) + Intravenous Immunoglobulin (IVIG) as Desensitization (DES) Agents for Reduction of Donor Specific Antibodies (DSA) in Patients Resistant to DES With IVIG + Rituximab

A. Vo, J. Choi, I. Kim, J. Kahwaji, A. Peng, R. Villicana, S. Jordan.
Extended Life-Supporting Xenogeneic Lung Function With Multi-Transgeneic Donor Pigs and Targeted Drug Treatments

L. Burdorf,¹ E. Rybak,¹ T. Zhang,¹ D. Harris,¹ S. Dahi,¹ N. Kubicki,¹ D. Parsell,¹ E. Sievert,¹ D. Ayares,² A. Azimzadeh,¹ R. Pierson III.¹
External Validation of Clinical Prediction Models of Patient and Graft Survival in a Canadian Cohort of Kidney Transplant Recipients

S. Singh,^1,2 D. Naimark,^1,2,3 J. Victor,² J. Kim.^1,2,4,5
Extracorporeal Life Support: A Rescue Therapy in a Lung Transplantation Program

P. Mohite, D. Gacia-Saez, B. Zych, N. Patil, M. Zeriouh, A. Koch, A.-F. Popov, A. Reed, M. Carby, F. DeRobertis, T. Bahrami, M. Amrani, S. Penn, S. Silver, S. Soresi, A. Simon.